An analysis of recent warning letters underscores the notion that FDA is focused its enforcement efforts on CBD, and is not targeting hemp extracts per se.
The European Food Safety Authority (EFSA) warns of consequences to the heart and cardiovascular system as a result of consuming large amounts of hemp products that includes supplements, teas and energy drinks.